Evidence map›Paper›PMID 16479014›Full record

ArticleMolecular and cellular biology2006

The proteasome is required for rapid initiation of death receptor-induced apoptosis.

Dennis Sohn, Gudrun Totzke, Frank Essmann, Klaus Schulze-Osthoff, Bodo Levkau, Reiner U Jänicke

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Proteasome complexes experience profound structural and functional rearrangements throughout mammalian spermatogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Identification ofOncology letters · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Proteasome inhibition improves diaphragm function in congestive heart failure rats.American journal of physiology. Lung cellular and molecular physiology · 2008
    Article
  16. Article
  17. Inhibition of ubiquitin-mediated degradation of MOAP-1 by apoptotic stimuli promotes Bax function in mitochondria.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Dennis SohnInstitute of Molecular Medicine, University of Düsseldorf, Building 23.12, Universitätsstrasse 1, D-40225 Düsseldorf, Germany.
Gudrun Totzke
Frank Essmann
Klaus Schulze-Osthoff
Bodo Levkau
Reiner U Jänicke
Institute of Molecular Medicine · INResearch Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to their tremendous apoptosis-inducing potential, proteasomal inhibitors (PIs) have recently entered clinical trials. Here we show, however, that various PIs rescued proliferating tumor cells from death receptor-induced apoptosis. This protection correlated with the stabilization of X-linked IAP (XIAP) and c-FLIP and the inhibition of caspase activation. Together with the observation that PIs could not protect cells expressing XIAP or c-FLIP short interfering RNAs (siRNAs) from death receptor-induced apoptosis, our results demonstrate that PIs mediate their protective effect via the stabilization of these antiapoptotic proteins. Furthermore, we show that once these proteins were eliminated, either by long-term treatment with death receptor ligands or by siRNA-mediated suppression, active caspases accumulated to an even larger extent in the presence of PIs. Together, our data support a biphasic role for the proteasome in apoptosis, as they show that its constitutive activity is crucial for the rapid initiation of the death program by eliminating antiapoptotic proteins, whereas at later stages, the proteasome acts in an antiapoptotic manner due to the proteolysis of caspases. Thus, for a successful PI-based tumor therapy, it is crucial to carefully evaluate basal proteasomal activity and the status of antiapoptotic proteins, as their PI-mediated prolonged stability might even cause adverse effects, leading to the survival of a tumor.

Indexed as

ApoptosisApoptosis Regulatory ProteinsCASP8 and FADD-Like Apoptosis Regulating ProteinCaspasesDeath Domain Receptor Signaling Adaptor ProteinsDose-Response Relationship, DrugEnzyme ActivationEnzyme Inhibitorsfas ReceptorHeLa CellsHumansIntracellular Signaling Peptides and ProteinsLeupeptinsMembrane GlycoproteinsProteasome Endopeptidase ComplexProteasome InhibitorsApoptosis Regulatory Proteinsbenzyloxycarbonylleucyl-leucyl-leucine aldehydeCASP8 and FADD-Like Apoptosis Regulating ProteinCaspasesCFLAR protein, humanDeath Domain Receptor Signaling Adaptor ProteinsEnzyme Inhibitorsfas ReceptorIntracellular Signaling Peptides and ProteinsLeupeptinsMembrane GlycoproteinsProteasome Endopeptidase ComplexProteasome InhibitorsReceptors, Tumor Necrosis FactorRNA, Small InterferingTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, humanTumor Necrosis Factor-alphaTumor Necrosis Factor Receptor-Associated Peptides and ProteinsX-Linked Inhibitor of Apoptosis Protein

Identifiers

PMID16479014
PMCPMC1430261
OpenAlexW2116345705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.